8-K filing — Crinetics Pharmaceuticals, Inc. (CRNX)
Filed: 2026-08-19 AccNo: 0001140361-26-033738 Size: 425 KB Item 8.01: Other Events
Read original at edgarStocks · News reference
Dow Gains Over 200 Points; US Trade Deficit Widens In May
US stocks traded mixed, with the Dow gaining over 200 points as healthcare shares jumped and information technology stocks fell. Trade deficit rose.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 7, 2026, 1:41 PM
- Checked
- Jul 7, 2026, 1:45 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Top 3 Health Care Stocks That May Implode In August
3 health care stocks with high momentum could be overbought. Crinetics Pharmaceuticals (CRNX) has RSI of 90.6, Alamar Biosciences (ALMR) at 86.8, and Halozyme Therapeutics (HALO) at 81.7.
Read original at benzingaCrinetics Will Not Provide Updated Guidance, Withdraws Prior Outlook Following Vertex Deal Announcement
Business Outlook and Conference CallIn light of Crinetics’ July 6, 2026 announcement regarding the proposed transaction with Vertex, Crinetics will not be providing updated guidance and is withdrawing its previously
Read original at benzingaCrinetics Pharmaceuticals Q2 EPS $(1.14) Beats $(1.24) Estimate, Sales $25.118M Beat $14.840M Estimate
Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(1.14) per share which beat the analyst consensus estimate of $(1.24) by 8.06 percent. This is a 7.32 percent increase over losses of $(1.23) per
Read original at benzingaThis Ascendis Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday
Analysts initiate coverage and change ratings on top stocks like ASND, DOCN, ODTX, MT, and NVCT. See their price targets and views on these stocks.
Read original at benzingaDigitalOcean Holdings shares are trading higher after Truist Securities initiated coverage on the stock with a Buy rating and announced a $175 price target.
Read original at benzinga